Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

authID Inc. Director's Dealing 2017

Nov 13, 2017

34633_dirs_2017-11-13_cd6eef32-c25e-4b57-afea-ca083f552bec.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ipsidy Inc. (IDGS)
CIK: 0001534154
Period of Report: 2017-09-29

Reporting Person: Beck Philip D (Director, CEO, Pres. and Chairman, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-09-29 Common Stock, $.0001 par value J 15000000 $0.0001 Acquired 16000000 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Options $0.10 2027-01-31 Common Stock, $0.0001 par value per share (15000000) 15000000 Direct
Stock Options $0.05 2026-08-10 Common Stock, $0.0001 par value per share (20000000) 20000000 Indirect

Footnotes

F1: September 29, 2017, the Company and Mr. Beck entered into a Restricted Stock Agreement pursuant to which Mr. Beck purchased 15 million shares of common stock at a per share price of $0.0001 pursuant to the terms of Mr. Beck's offer letter. The shares vest upon the terms set forth in Mr. Beck's Restricted Stock Agreement.

F2: The Stock Options vest with respect to (i) one-third of the shares of common stock upon January 31, 2017 and (ii) in 24 equal monthly tranches commencing on the January 31, 2017.

F3: On August 10, 2016, Ipsidy Inc. (the "Company") entered into an amended agreement (the "Amendment") with Parity Labs, LLC ("Parity"), a private consulting firm which is principally owned by Mr. Beck, to amend the compensation section of the Advisory Agreement previously entered into between the Company and Parity on November 16, 2015 for the provision of strategic advisory services. Pursuant to the Amendment, the Company issued Parity an option (the "Parity Option") to acquire 20 million shares of common stock of the Company, exercisable at $0.05 per share for a period of ten years. The Parity Option vested as to 10 million shares of common stock immediately and then initially in 12 equal tranches of 833,333 shares per month commencing on September 1, 2016, which such vesting was accelerated with respect to all remaining shares of common stock that were unvested under the Parity Option as a result of Mr. Beck's appointment as a director of the Company.